BlackRock Group’s Auspex Pharmaceuticals ASPX Stock Holding History
Bought
Maintained
Sold
BlackRock Group's ASPX Position: Q2 2015 in Review
BlackRock Group sold out of Auspex Pharmaceuticals (ASPX) in Q2 2015, closing a stake of 5,796 shares — an estimated $581K sold.
BlackRock Group first reported a position in ASPX in Q2 2014 and held it in 2 quarters. The position peaked at $581K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.
- BlackRock Group reported no remaining Auspex Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
- BlackRock Group sold 5,796 Auspex Pharmaceuticals shares in Q2 2015, an estimated $581K.
- BlackRock Group first reported a position in Auspex Pharmaceuticals in Q2 2014 and held it in 2 quarters.
- BlackRock Group's Auspex Pharmaceuticals position peaked at $581K in Q1 2015.
- 0 funds tracked by Wall St. Rank held Auspex Pharmaceuticals as of Q2 2015.
Based on BlackRock Group's 13F filing for Q2 2015, filed 7 Aug 2015.